Caplight Directory>Investors>Brace Pharma Capital>Brace-pharma-capital


Brace Pharma Capital

Brace Pharma Capital

Atlanta, Georgiabracepharma.com

Overview

Brace Pharma Capital is a strategic investment firm formed by EMS S/A, the largest pharmaceutical company in Brazil, and high net worth biotech investors . They invest in innovative, life changing therapies for diseases with a high degree of unmet medical need and insufficient treatment options .

Year Founded

2013

Portfolio Companies

5

Investments

CompanyDateStageLead
Antiva BiosciencesNov 2021Series D-
ReViralAug 2020Series C-
F2gAug 2020Series F-
ReViralAug 2018Series BCo-investor
Antiva BiosciencesJul 2018Series C Extension-

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersAtlanta, Georgia
Year Founded2013

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.